Clarity Pharmaceuticals shares today surged 40% after the FDA granted 'breakthrough designation" for the company's prostate ...

Copper has been getting sold off with equities hit harder. Argonaut's David Franklyn sees value in these juniors putting runs ...

Clarity Pharmaceuticals (ASX:CU6) has scored the FDA’s first Breakthrough Therapy designation for a PSMA PET imaging agent, with its copper-64 SAR-bisPSMA scan showing promise in detecting recurring ...

After some back-to-back wins, the ASX coughed up a loss on Thursday, slipping 0.07% as miners got kicked around and tech did ...

These ASX explorers have joined the 1 million ounce club but are turning to the drill bit in the search for more gold.

Several ASX companies are undertaking pivotal phase III trials with Dimerix working particularly hard on its trial design to ...

South Australia was fourth in the latest Fraser Institute global survey, beating WA in sixth, and these juniors explain why ...

Silver’s growing industrial role is lifting its outlook, while NSW’s rich deposits and rising exploration activity put ...

WhiteRock Lithium believes its Banana lithium deposit in Canada has the scale and grade to ride out the cycles. Next stop: ...

Victory signs agreement with Curtin University to access its $18.4m processing facility; Heavy rare earth concentrate from ...

The ASX barely budged as tech stocks perked up, miners slipped and CBA served up another $2.8 billion in profit.

Wall Street's AI sell-off has rattled the big players, but a handful of ASX tech minnows could find opportunity in the ...